Stock listing
NASDAQ:CMND Clearmind Medicine Inc. Stock
Home listing (NASDAQ) of Clearmind Medicine Inc.
Follow Clearmind Medicine Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CMND
$6.14 USD -0.08 (-1.3%)
Close on Nov 2, 2026
- Day range
- $6.02 – $6.14 USDNov 2, 2026
- Volume
- 1,827 sharesNov 2, 2026
- Market cap
- $3.12M USDAt the close on Nov 2, 2026 · price × 507,404 shares outstanding
- 52-week range
- $5.25 – $2,688.00 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $103,478 USDMedian day 2,991 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CMND · Home | $6.14 USD | -0.079 (-1.3%) | 1,827 | $6.02 | $6.14 | $6.02 | $6.219 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CMND · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.14 | -0.079 | -1.3% | $6.02 | $6.14 | $6.02 | 1,827 | |
| $6.219 | +0.369 | +6.3% | $5.83 | $6.499 | $5.83 | 9,470 | |
| $5.85 | -0.21 | -3.5% | $6.15 | $6.15 | $5.85 | 4,301 | |
| $6.06 | +0.093 | +1.6% | $6.00 | $6.10 | $5.98 | 5,022 | |
| $5.967 | -0.154 | -2.5% | $6.095 | $6.095 | $5.948 | 5,341 | |
| $6.121 | +0.251 | +4.3% | $5.92 | $6.20 | $5.86 | 16,232 | |
| $5.87 | -0.13 | -2.2% | $6.255 | $6.255 | $5.87 | 8,342 | |
| $6.00 | +0.06 | +1.0% | $6.01 | $6.04 | $6.00 | 5,297 | |
| $5.94 | -0.18 | -2.9% | $6.253 | $6.253 | $5.94 | 5,216 | |
| $6.12 | +0.12 | +2.0% | $5.971 | $6.14 | $5.91 | 6,974 | |
| $6.00 | -0.26 | -4.2% | $6.164 | $6.362 | $5.91 | 8,271 | |
| $6.26 | -0.16 | -2.5% | $6.33 | $6.47 | $6.26 | 4,137 | |
| $6.42 | +0.131 | +2.1% | $6.24 | $6.79 | $6.24 | 5,684 | |
| $6.289 | +0.059 | +0.9% | $6.36 | $6.47 | $6.20 | 10,814 | |
| $6.23 | -0.31 | -4.7% | $6.50 | $6.73 | $6.23 | 11,000 | |
| $6.54 | -0.04 | -0.6% | $6.52 | $6.80 | $6.481 | 16,100 | |
| $6.58 | -0.02 | -0.3% | $6.77 | $6.94 | $6.35 | 9,100 | |
| $6.60 | 0.00 | 0.0% | $6.64 | $7.16 | $6.40 | 41,100 | |
| $6.60 | +0.76 | +13.0% | $5.75 | $6.70 | $5.54 | 146,400 | |
| $5.84 | -0.16 | -2.7% | $5.89 | $6.175 | $5.701 | 35,400 | |
| $6.00 | +0.28 | +4.9% | $5.93 | $6.54 | $5.25 | 89,200 | |
| $5.72 | -0.008 | -0.1% | $5.92 | $5.92 | $5.648 | 1,522 | |
| $5.728 | -0.712 | -11.1% | $6.00 | $6.096 | $5.672 | 3,428 | |
| $6.44 | -0.048 | -0.7% | $6.52 | $6.72 | $6.40 | 1,559 | |
| $6.488 | +0.184 | +2.9% | $6.256 | $6.576 | $6.256 | 538 | |
| $6.304 | -0.12 | -1.9% | $6.40 | $6.544 | $6.264 | 1,422 | |
| $6.424 | -0.056 | -0.9% | $6.72 | $6.72 | $6.416 | 886 | |
| $6.48 | -0.32 | -4.7% | $6.808 | $6.808 | $6.40 | 978 | |
| $6.80 | +0.552 | +8.8% | $6.432 | $6.80 | $6.24 | 5,839 | |
| $6.248 | -0.08 | -1.3% | $6.24 | $6.32 | $6.176 | 1,169 | |
| $6.328 | -0.064 | -1.0% | $6.32 | $6.40 | $6.20 | 1,883 | |
| $6.392 | -0.472 | -6.9% | $6.80 | $6.864 | $6.16 | 2,991 | |
| $6.864 | +0.416 | +6.5% | $6.592 | $8.48 | $6.504 | 24,967 | |
| $6.448 | -0.464 | -6.7% | $6.728 | $6.776 | $6.32 | 2,399 | |
| $6.912 | -0.64 | -8.5% | $7.344 | $7.464 | $6.664 | 2,613 | |
| $7.552 | -0.184 | -2.4% | $7.52 | $7.76 | $7.336 | 2,561 | |
| $7.736 | -0.12 | -1.5% | $8.00 | $8.48 | $7.60 | 4,433 | |
| $7.856 | -0.624 | -7.4% | $8.00 | $8.36 | $7.84 | 1,581 | |
| $8.48 | +0.24 | +2.9% | $8.56 | $8.88 | $8.00 | 5,134 | |
| $8.24 | -1.04 | -11.2% | $9.20 | $9.20 | $7.36 | 48,711 | |
| $9.28 | -4.32 | -31.8% | $11.96 | $12.44 | $9.28 | 242,381 | |
| $13.60 | -1.20 | -8.1% | $14.48 | $14.72 | $13.60 | 922 | |
| $14.80 | +0.16 | +1.1% | $14.80 | $14.96 | $14.32 | 694 | |
| $14.64 | -0.88 | -5.7% | $15.44 | $15.44 | $14.08 | 3,378 | |
| $15.52 | +1.44 | +10.2% | $14.56 | $16.80 | $14.48 | 11,170 | |
| $14.08 | -0.40 | -2.8% | $14.56 | $14.72 | $13.84 | 384 | |
| $14.48 | +0.72 | +5.2% | $14.80 | $14.80 | $14.00 | 1,019 | |
| $13.76 | +0.08 | +0.6% | $13.44 | $13.92 | $13.28 | 567 | |
| $13.68 | +0.24 | +1.8% | $13.52 | $14.00 | $13.20 | 664 | |
| $13.44 | -0.48 | -3.4% | $14.00 | $14.00 | $12.88 | 1,516 | |
| $13.92 | +0.08 | +0.6% | $13.92 | $14.68 | $13.92 | 717 | |
| $13.84 | -1.44 | -9.4% | $15.44 | $15.44 | $13.60 | 1,709 | |
| $15.28 | -0.40 | -2.6% | $15.68 | $15.68 | $15.04 | 991 | |
| $15.68 | +0.56 | +3.7% | $15.04 | $18.48 | $14.72 | 13,056 | |
| $15.12 | +0.24 | +1.6% | $15.04 | $15.76 | $14.88 | 716 | |
| $14.88 | +0.08 | +0.5% | $15.04 | $15.12 | $14.56 | 567 | |
| $14.80 | +1.60 | +12.1% | $13.52 | $14.88 | $13.52 | 3,245 | |
| $13.20 | +0.32 | +2.5% | $12.88 | $13.36 | $12.80 | 936 | |
| $12.88 | +0.08 | +0.6% | $12.72 | $13.28 | $12.32 | 1,109 | |
| $12.80 | -0.24 | -1.8% | $13.12 | $13.36 | $12.64 | 420 | |
| $13.04 | -0.96 | -6.9% | $13.92 | $14.08 | $12.64 | 1,230 | |
| $14.00 | -0.08 | -0.6% | $13.92 | $14.08 | $13.68 | 1,081 | |
| $14.08 | +0.40 | +2.9% | $13.44 | $14.40 | $13.44 | 2,069 | |
| $13.68 | +0.64 | +4.9% | $12.64 | $14.16 | $12.64 | 1,678 | |
| $13.04 | -0.48 | -3.6% | $12.40 | $13.44 | $12.16 | 5,853 |
- Ticker
- NASDAQ:CMND
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial
Oct 27, 2026
Closed $5.97 (-2.5%) on Oct 27, 2026
Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder
Oct 8, 2026
Closed $6.60 (0.0%) on Oct 8, 2026
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
Oct 7, 2026
Closed $6.60 (+13.0%) on Oct 7, 2026
Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations
Sep 23, 2026
Closed $6.80 (+8.8%) on Sep 23, 2026
Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.
Sep 17, 2026
Closed $6.86 (+6.5%) on Sep 17, 2026
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
Sep 11, 2026
Closed $7.74 (-1.5%) on Sep 11, 2026
Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
Sep 8, 2026
Closed $8.24 (-11.2%) on Sep 8, 2026
Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis
Sep 4, 2026
Closed $9.28 (-31.8%) on Sep 4, 2026
Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
Sep 1, 2026
Closed $14.64 (-5.7%) on Sep 1, 2026
Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Aug 24, 2026
Closed $13.44 (-3.4%) on Aug 24, 2026
Decks
Investor Presentation (November 2025)
Investor deck · 24 slides · November 2025
Investor Presentation (July 2025)
Investor deck · 24 slides · Jul 29, 2025
Investor Presentation (October 2024)
Investor deck · 19 slides · October 2024
Investor Presentation (August 2024)
Investor deck · 13 slides · Aug 20, 2024
Clearmind Medicine Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 73 in the last 12 months · 166 in all · newest Oct 27, 2026 · oldest 2022
- Decks
- 4 decks · latest November 2025
Where Clearmind Medicine Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CMND · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CMND | BOATS | United States | USD |
| gettex:CWY | gettex | Germany | EUR |
| Lang & Schwarz:A41YK5 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A41YK5 | LS Exchange | Germany | EUR |
| Frankfurt:CWY0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A427B1 | Lang & Schwarz | Germany | EUR |
| Munich:CWY | Munich | Germany | USD |
| Munich:CWY0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Clearmind Medicine Inc.